Browse All
Displaying 801 - 805 of 2174
Author:Nakamura, Kunio Husak, Scott Bermel, Robert Cohen, Jeffrey Ontaneda, Daniel
Session Name:P10: MS Neuroimaging 1
Topic:MS and Inflammatory Disease
Program Number:P10.011
Author Institution:Cleveland Clinic, Cleveland, OH
Author:Harris, Sarah Vermersch, Patrick Montalban, Xavier Hartung, Hans-Peter Kappos, Ludwig Southworth, Harry Sheffield, James K. Silva, Diego Cohen, Jeffrey A.
Session Name:P1: MS Biomarkers
Program Number:P1.012
Author Institution:Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ Univ. Lille, Inserm UMR U1172, CHU Lille, FHU Precise, Lille, France, Lille, France Department of Neurology-Neuroimmunology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain, Barcelona, Spain Department of Neurology, Medical Faculty, Heinrich-Heine University, Düsseldorf, Germany Brain and Mind Centre, University of Sydney, Sydney, Australia Department of Neurology, Medical University of Vienna, Vienna, Austria and Palacký University Olomouc, Olomouc, Czech Republic, Olomouc, Czech Republic Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland Data Clarity Consulting Ltd, Stockport, England, United Kingdom, England, United Kingdom Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, Cleveland, OH
Author:DeLuca, John Cohen, Jeffrey A. Cree, Bruce A. C. Cheng, Chun-Yen Sheffield, James K. Riolo, Jon V. Silva, Diego Comi, Giancarlo Kappos, Ludwig
Session Name:P6: MS Clinical Trials
Program Number:P6.001
Author Institution:Kessler Foundation, West Orange, New Jersey, and Departments of Physical Medicine and Rehabilitation, and Neurology, Rutgers - New Jersey Medical School, Newark, New Jersey, West Orange, NJ Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, Cleveland, OH Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, San Francisco, CA Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ Vita-Salute San Raffaele University, and Casa di Cura del Policlinico, Milan, Italy, Milan, Italy Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland
Author:Cree, Bruce A. C. Danese, Silvio Wolf, Douglas C. Alekseeva, Olga Charles, Lorna Petersen, AnnKatrin Sheffield, James K. Cheng, Chun-Yen Riolo, Jon V. Silva, Diego Lublin, Fred D. Rubin, David T. Cohen, Jeffrey A.
Session Name:P7: MS Therapeutics 1
Program Number:P7.007
Author Institution:Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, San Francisco, CA Humanitas University, Milan, Italy, Milan, Italy Atlanta Gastroenterology Associates, LLC, Atlanta, Georgia, Atlanta, GA Nizhegorodskaya Regional Clinical, Nizhegorodskaya oblast' Russia, Nizhegorodskaya oblast' , Russian Federation Bristol Myers Squibb, Princeton, New Jersey, Princeton, NJ Mount Sinai Medical Center, New York, New York, New York, NY University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, Chicago, IL Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, Ohio, Cleveland, OH
Author:Amanat, Man Cohen, Julie S. Fatemi, Ali Fine, Amena
Session Name:P4: Behavioral and Cognitive Neurology: Language Disorders, Multiple Sclerosis and Case Reports in Behavioral and Cognitive Neurology
Topic:Behavioral and Cognitive Neurology
Program Number:P4.010
Author Institution:Kennedy Krieger Institute, Baltimore, MD
